These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4607702)

  • 1. Diencephalic involvement in generalized lipodystrophy: rationale and treatment with the neuroleptic agent, pimozide.
    Corbin A; Upton GV; Mabry CC; Hollingsworth DR
    Acta Endocrinol (Copenh); 1974 Oct; 77(2):209-20. PubMed ID: 4607702
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic studies and autonomic function in children with partial lipodystrophy.
    West RJ; Fosbrooke AS; Lloyd JK
    Arch Dis Child; 1974 Aug; 49(8):627-32. PubMed ID: 4418207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fat cell size and lipid content of subcutaneous tissue in congenital generalized lipodystrophy.
    Rognum TO; Bjerve KS; Seip M; Trygstad O; Oseid S
    Acta Endocrinol (Copenh); 1978 May; 88(1):182-9. PubMed ID: 580534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a specific dopaminergic blocking agent, pimozide, on hypothalamic corticotropin-releasing-factor activity in rats: clinical correlates.
    Upton GV; Corbin A
    Experientia; 1975 Feb; 31(2):249-50. PubMed ID: 1078659
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Management of lipoatrophic diabetes.
    Upton GV; Corbin A; Mabry CC; Hollingsworth DR
    N Engl J Med; 1975 Mar; 292(11):592. PubMed ID: 1110678
    [No Abstract]   [Full Text] [Related]  

  • 6. Pituitary-hypothalamic dysfunction in generalized lipodystrophy.
    Mabry CC; Hollingsworth DR; Upton GV; Corbin A
    J Pediatr; 1973 Apr; 82(4):625-33. PubMed ID: 4121462
    [No Abstract]   [Full Text] [Related]  

  • 7. Congenital generalized lipodystrophy and experimental lipoatrophic diabetes in rabbits treated successfully with fenfluramine.
    Trygstad O; Foss I
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):436-48. PubMed ID: 577333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital generalized lipodystrophy.
    Kaplan BS
    S Afr Med J; 1970 Aug; 44(33):945-8. PubMed ID: 4318181
    [No Abstract]   [Full Text] [Related]  

  • 9. Congenital generalized lipodystrophy.
    Jafri N; Zaidi Z
    J Pak Med Assoc; 1992 Mar; 42(3):74-6. PubMed ID: 1630004
    [No Abstract]   [Full Text] [Related]  

  • 10. Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry.
    Pinder RM; Brogden RN; Swayer R; Speight TM; Spencer R; Avery GS
    Drugs; 1976; 12(1):1-40. PubMed ID: 824116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and endocrine studies in a case of lipoatrophic diabetes.
    Rossini AA; Self J; Aoki TT; Goldman RF; Newmark SR; Meguid MM; Soeldner JS; Cahill GF
    Metabolism; 1977 Jun; 26(6):637-50. PubMed ID: 870793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of depo-provera on carbohydrate, lipids and vitamin metabolism.
    Amatayakul K
    J Steroid Biochem; 1979 Jul; 11(1B):475-81. PubMed ID: 491619
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased growth hormone in partial and total lipoatrophy.
    Tzagournis M; George J; Herrold J
    Diabetes; 1973 May; 22(5):388-96. PubMed ID: 4700052
    [No Abstract]   [Full Text] [Related]  

  • 14. The action of chlorpromazine on diencephalic sympathetic activity and on the release of adrenocorticotrophic hormone.
    HOLZBAUER M; VOGT M
    Br J Pharmacol Chemother; 1954 Dec; 9(4):402-7. PubMed ID: 13219261
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic effects of aripiprazole and pimozide in children with Tourette syndrome.
    Rizzo R; Eddy CM; Calí P; Gulisano M; Cavanna AE
    Pediatr Neurol; 2012 Dec; 47(6):419-22. PubMed ID: 23127261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Management of lipoatrophic diabetes.
    Senior B; Gellis SS
    N Engl J Med; 1975 Jun; 292(23):1243. PubMed ID: 1128582
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of pimozide, a dopaminergic blocking agent, on hypothalamic luteinizing hormone releasing hormone activity in hypophysectomized rats.
    Corbin A; Beattie CW; Upton GV
    Experientia; 1975 May; 31(5):613-4. PubMed ID: 1095388
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of dopaminergic blocking agents on plasma luteinizing hormone releasing hormone activity in hypophysectomized rats.
    Corbin A; Upton GV
    Experientia; 1973 Dec; 29(12):1552-3. PubMed ID: 4589326
    [No Abstract]   [Full Text] [Related]  

  • 19. The relation between insulin and growth hormone and blood plasma levels of triglycerides and total cholesterol in healthy mothers at delivery and in their newborn infants.
    Jaśkiewicz J; Szafran Z; Szafran H; Sztefko K; Brylska U
    Endokrynol Pol; 1985; 36(3):155-62. PubMed ID: 3908083
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of gonadotropin-releasing hormone-stimulated luteinizing hormone release by pimozide: evidence for a site of action after calcium mobilization.
    Conn PM; Rogers DC; Sheffield T
    Endocrinology; 1981 Oct; 109(4):1122-6. PubMed ID: 6793346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.